About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 46 record(s)
Req # A-2020-00022
Temporary Help Services (THS) Supply Arrangement (SA) and Standing Offer (SO) callups issued in the National Capital Region for the months of July, August and September 2020.Organization: Social Sciences and Humanities Research Council of Canada
November 2020
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2020-00016
Total expenses incurred under financial object codes 1231, 1246, and 0533 since March 1, 2020.Organization: Social Sciences and Humanities Research Council of Canada
October 2020
Req # A-2020-00017
Grants and contributions of $25,000 or more granted since April 1, 2015.Organization: Social Sciences and Humanities Research Council of Canada
October 2020
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-00009
Records related to Benedict McKay's 2012 Doctoral Fellowships application entitled "Assessing the impacts of divergent agricultural development strategies on rural livelihoods and food security: a comparative case study of Bolivia and Venezuela" and the 2018 Insight Development Grant application entitled "Food sovereignty and neo-extractivism: limits and possibilities, convergences and contradictions," including reports on the use of grant funds and the outcomes and impact of the research.Organization: Social Sciences and Humanities Research Council of Canada
September 2020
Req # A-2020-01436
Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020